Enlivex Therapeutics Ltd (ENLV) — Cash Flow Reinvestment Rate
Latest as of March 2020:
2.62x
Enlivex Therapeutics Ltd (ENLV) has a Cash Flow Reinvestment Rate of 2.62x as of March 2020, reinvesting ILA2.04 Million (capex ILA39.00K plus investments ILA-2.00 Million) from operating cash flow of ILA779.00K. Explore capital reinvestment ratio of Enlivex Therapeutics Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
2.62x
(Capex + Investments) / Operating CF
Total Reinvested
ILA2.04 Million
Capex + Investments
Operating Cash Flow
ILA779.00K
ILA
Capital Expenditures
ILA39.00K
ILA
Annual Cash Flow Reinvestment Rate for Enlivex Therapeutics Ltd (None–None)
Year-by-year capital reinvestment analysis for Enlivex Therapeutics Ltd. For live market cap and broader valuation context, see ENLV market cap overview.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow